Clinical Trial Detail

NCT ID NCT02663271
Title TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Florida
Indications

glioblastoma multiforme

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.